Olga M Kukanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olga M Kukanova has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anatoly Nikolaevich Kondratyev
Polenov Neurosurgical Institute, Branch of the Almazov National Medical Research Centre
2 shared publications - Elena G. Potyomkina
Almazov National Medical Research Centre
2 shared publications - Konstatin Konstantinovich Kukanov
Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre
2 shared publications - Malik M. Tastanbekov
Almazov National Medical Research Centre
2 shared publications - Natalia Evgenievna Ivanova
Federal State Budgetary Institution “V. A. Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
2 shared publications - V. V. Ushanov
Almazov National Medical Research Centre
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 148-156
OSMOTIC DEMYELINATING SYNDROME: A CASE OF SUCCESSFUL TREATMENT
Osmotic demyelinating syndrome (ODS) is a rare but extremely severe lesion of the central nervous system due to water-electrolyte disorders. The most common cause of ODS, in 30-78% of cases, is previous hyponatremia. Violation of water-electrolyte metabolism is one of the most common complications of the course of critical ills. Hyponatremia often develop in patients with severe brain, liver, and kidney damage, and are the cause of hospitalization in children and the elderly. Rapid correction of chronic hyponatremia can lead to the development of osmotic demyelinating syndrome, manifested by severe neurological deficiency, which often causes severe disability and death of the patient. Depending on the affected area, pontine and extrapontine myelinolysis are distinguished.In addition to hyponatremia, risk factors for the development of ODS include hypokalemia, hypophosphatemia, alcoholism, hypotrophy, infectious and inflammatory processes. Prevention of the development of ODS consists in a personalized approach to the correction of hyponatremia and hypoosmolarity of plasma. Too slow a correction can lead to ongoing cerebral edema, and too fast can lead to irreversible demyelination. Currently, there are no etiopathogenetic treatments for ODS. Our clinical case demonstrates that a comprehensive, team-based approach to the rehabilitation of a patient with ODS has achieved good results
- 26 June 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 148-156
Open AccessOSMOTIC DEMYELINATING SYNDROME: A CASE OF SUCCESSFUL TREATMENT
Osmotic demyelinating syndrome (ODS) is a rare but extremely severe lesion of the central nervous system due to water-electrolyte disorders. The most common cause of ODS, in 30-78% of cases, is previous hyponatremia. Violation of water-electrolyte metabolism is one of the most common complications of the course of critical ills. Hyponatremia often develop in patients with severe brain, liver, and kidney damage, and are the cause of hospitalization in children and the elderly. Rapid correction of chronic hyponatremia can lead to the development of osmotic demyelinating syndrome, manifested by severe neurological deficiency, which often causes severe disability and death of the patient. Depending on the affected area, pontine and extrapontine myelinolysis are distinguished.In addition to hyponatremia, risk factors for the development of ODS include hypokalemia, hypophosphatemia, alcoholism, hypotrophy, infectious and inflammatory processes. Prevention of the development of ODS consists in a personalized approach to the correction of hyponatremia and hypoosmolarity of plasma. Too slow a correction can lead to ongoing cerebral edema, and too fast can lead to irreversible demyelination. Currently, there are no etiopathogenetic treatments for ODS. Our clinical case demonstrates that a comprehensive, team-based approach to the rehabilitation of a patient with ODS has achieved good results
- 5 June 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (5) , 125-133
Foix—Alajouanine syndrome as a variant of a spinal dural arteriovenous fistula
The epidemiology of Foix—Alajouanine syndrome (FAS) remains poorly characterized. Accurate data on the prevalence of FAS In Russia are not available; in Germany, only 5—10 cases per 1 million population are reported. The article reviews data from the current literature on FAS and presents a clinical case of a patient with a dural arteriovenous fistula at the level of the craniovertebral junction with severe circulatory disorders at the upper cervical level of the spinal cord, with progressive severe focal neurological deficit, despite endovascular surgery. The disease-associated syndromes are described in detail, including the chronic critical condition, as well as the rehabilitation approach for this patient. The indications for surgery and choosing a treatment method for this patient, considering an extremely high risk of irreversible spinal circulatory disorders, were debatable.
- 5 June 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (5) , 125-133
Foix—Alajouanine syndrome as a variant of a spinal dural arteriovenous fistula
The epidemiology of Foix—Alajouanine syndrome (FAS) remains poorly characterized. Accurate data on the prevalence of FAS In Russia are not available; in Germany, only 5—10 cases per 1 million population are reported. The article reviews data from the current literature on FAS and presents a clinical case of a patient with a dural arteriovenous fistula at the level of the craniovertebral junction with severe circulatory disorders at the upper cervical level of the spinal cord, with progressive severe focal neurological deficit, despite endovascular surgery. The disease-associated syndromes are described in detail, including the chronic critical condition, as well as the rehabilitation approach for this patient. The indications for surgery and choosing a treatment method for this patient, considering an extremely high risk of irreversible spinal circulatory disorders, were debatable.
- Open Access
- 15 December 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (4) , 176-184
Recurrent intracranial meningiomas (review and clinical case report)
INTRODUCTION. Meningiomas are the second most common central nervous system (СNS) tumors after gliomas in adults. The overall rate of meningioma recurrence is 14–33 % according to different authors.PURPOSE. To discuss the challenges in diagnosis and treatment of recurrent meningiomas, to assess the clinical features and adjuvant treatment options. To present a clinical case of comprehensive treatment of intracranial meningioma recurrence.MATERIAL AND METHODS. We searched for publications in the Pubmed, EMBASE, Cohrane Library and eLibrary databases published between January 2000 and January 2019 on the issue of recurrent intracranial meningiomas, in particular atypical and anaplastic meningiomas. The clinical case of supratentorial meningioma recurrence is reported.RESULTS. The review systematizes data on the prognostic factors for survival, relapse-free period, and disease progression. Particular attention was paid to the radical resection of the tumor and the assessment of the grade of anaplasia. The current data on adjuvant treatment options were presented. The controversial issues of approaches to the assessment of morphological prognostic criteria were discussed.
- 15 December 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (4) , 176-184
Open AccessRecurrent intracranial meningiomas (review and clinical case report)
INTRODUCTION. Meningiomas are the second most common central nervous system (СNS) tumors after gliomas in adults. The overall rate of meningioma recurrence is 14–33 % according to different authors.PURPOSE. To discuss the challenges in diagnosis and treatment of recurrent meningiomas, to assess the clinical features and adjuvant treatment options. To present a clinical case of comprehensive treatment of intracranial meningioma recurrence.MATERIAL AND METHODS. We searched for publications in the Pubmed, EMBASE, Cohrane Library and eLibrary databases published between January 2000 and January 2019 on the issue of recurrent intracranial meningiomas, in particular atypical and anaplastic meningiomas. The clinical case of supratentorial meningioma recurrence is reported.RESULTS. The review systematizes data on the prognostic factors for survival, relapse-free period, and disease progression. Particular attention was paid to the radical resection of the tumor and the assessment of the grade of anaplasia. The current data on adjuvant treatment options were presented. The controversial issues of approaches to the assessment of morphological prognostic criteria were discussed.
- Open Access
- 19 August 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (3) , 55-62
Clinical features in recurrence and progression of intracranial meningiomas
INTRODUCTION. Meningiomas account for 18–34 % of all intracranial tumors in adults and are the second most common among all intracranial neoplasms. Recurrence and progression account for 25 %, on average, even after radical tumor resection and radiotherapy., that worsens the prognosis and functional outcome of the disease significantly. Clinical manifestations often occur with large tumor sizes, initial symptoms are not taken into account by patients and by doctors during follow-up after surgery.PURPOSE. To assess the clinical features in patients with recurrence and progression of intracranial meningiomas and to identify the features of clinical manifestations in the progression of meningiomas.MATERIALS AND METHODS. The study was based on patients (105 cases) with recurrence and progression of intracranial meningiomas with Grade I – III according to histology, who were treated in the Department of Neurosurgery No. 4 of the Russian Neurosurgical Institute named after professor. A. L. Polenov in the period of time from 2014 to 2022. Assessment of clinical neurological symptoms was performed according to standard methods in clinical practice. The results were evaluated using the software system STATISTICA 10.0.RESULTS. The multifactorial analysis of the clinical manifestations of the disease in recurrent intracranial meningiomas was performed, the main trends in oncogenesis were identified, and the most common clinical symptoms of tumor progression were identified, which must be taken into account by doctors during follow-up after surgery.
- 19 August 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (3) , 55-62
Open AccessClinical features in recurrence and progression of intracranial meningiomas
INTRODUCTION. Meningiomas account for 18–34 % of all intracranial tumors in adults and are the second most common among all intracranial neoplasms. Recurrence and progression account for 25 %, on average, even after radical tumor resection and radiotherapy., that worsens the prognosis and functional outcome of the disease significantly. Clinical manifestations often occur with large tumor sizes, initial symptoms are not taken into account by patients and by doctors during follow-up after surgery.PURPOSE. To assess the clinical features in patients with recurrence and progression of intracranial meningiomas and to identify the features of clinical manifestations in the progression of meningiomas.MATERIALS AND METHODS. The study was based on patients (105 cases) with recurrence and progression of intracranial meningiomas with Grade I – III according to histology, who were treated in the Department of Neurosurgery No. 4 of the Russian Neurosurgical Institute named after professor. A. L. Polenov in the period of time from 2014 to 2022. Assessment of clinical neurological symptoms was performed according to standard methods in clinical practice. The results were evaluated using the software system STATISTICA 10.0.RESULTS. The multifactorial analysis of the clinical manifestations of the disease in recurrent intracranial meningiomas was performed, the main trends in oncogenesis were identified, and the most common clinical symptoms of tumor progression were identified, which must be taken into account by doctors during follow-up after surgery.